Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+0.98%
FTSE
+0.42%
N225
+0.80%
AXJO
+0.41%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
36.33B
Dividend Yield
0.00%
P/E Ratio
-204.54
EPS
-0.48
Revenue
3.81B
Avg. Volume
470.94K

Recently from Cashu

publisher logo
Cashu

BeOne Medicines Reports Promising Results for Sonrotoclax in Relapsed Mantle Cell Lymphoma

4 days ago
publisher logo
Cashu

BeiGene Advances Sonrotoclax Research for Relapsed/Refractory Mantle Cell Lymphoma Treatment

6 days ago
publisher logo
Cashu

BeiGene: BeOne Medicines Sells Royalty Rights to Capitalize on Oncology Market Potential

8 days ago

About

What does ONC do?
It seems there was an error or missing information in your request. Please provide the content you would like summarized, and I'll be happy to help!
Sector
💻 Health Care
IPO
CEO
Employees
11,000
Headquarters
Cayman Islands
Website
http://www.beigene.com
Stocks
Health Care
onc
BeiGene
SHANGHAI STOCK EXCHANGE: ONC
-17.67 (-5.25%)
318.59
USD
At close at Sep 04, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials